HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert H Getzenberg Selected Research

Nuclear Matrix-Associated Proteins

12/2009Identification of nuclear structural protein alterations associated with seminomas.
7/2008The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
5/2008The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
6/2007Characterization of nuclear matrix protein alterations associated with renal cell carcinoma.
2/2004Colon cancer specific nuclear matrix protein alterations in human colonic adenomatous polyps.
5/2003Identification of calreticulin as a nuclear matrix protein associated with human colon cancer.
2/2003Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer.
10/2002Nuclear matrix protein alterations associated with colon cancer metastasis to the liver.
4/2002Identification of nuclear matrix protein alterations associated with human colon cancer.
1/2002Nuclear matrix proteins as biomarkers in prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert H Getzenberg Research Topics

Disease

51Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2002
44Neoplasms (Cancer)
11/2020 - 01/2002
12Urinary Bladder Neoplasms (Bladder Cancer)
04/2012 - 02/2004
11Colonic Neoplasms (Colon Cancer)
01/2013 - 04/2002
10Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2013 - 06/2004
9Testicular Neoplasms (Testicular Cancer)
03/2015 - 12/2009
6Colorectal Neoplasms (Colorectal Cancer)
01/2013 - 02/2004
4Neoplasm Metastasis (Metastasis)
03/2014 - 10/2002
3Carcinogenesis
07/2015 - 06/2007
2Hot Flashes
12/2020 - 02/2015
2Disease Progression
11/2020 - 12/2010
2Carcinoma (Carcinomatosis)
11/2020 - 10/2014
2Pathologic Processes
04/2010 - 05/2009
2Polyps
05/2008 - 01/2006
2Renal Cell Carcinoma (Grawitz Tumor)
06/2007 - 04/2006
2Spinal Cord Injuries (Spinal Cord Injury)
10/2005 - 05/2005
1Diarrhea
01/2022
1Fatigue
01/2022
1Insulin Resistance
02/2015
1Circulating Neoplastic Cells
01/2013
17 Hereditary Prostate Cancer
06/2012

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2002
31Biomarkers (Surrogate Marker)IBA
03/2015 - 01/2002
16AntigensIBA
03/2015 - 05/2005
11Nuclear Matrix-Associated ProteinsIBA
12/2009 - 01/2002
9Prostate-Specific Antigen (Semenogelase)IBA
02/2015 - 04/2004
6AndrogensIBA
09/2020 - 01/2005
5Tumor Biomarkers (Tumor Markers)IBA
08/2008 - 01/2002
4Androgen Receptors (Androgen Receptor)IBA
01/2022 - 08/2003
4Hormones (Hormone)IBA
02/2015 - 07/2008
4Biological ProductsIBA
12/2011 - 11/2005
3Testosterone (Sustanon)FDA Link
12/2020 - 02/2015
3Pharmaceutical PreparationsIBA
11/2019 - 07/2005
3Paclitaxel (Taxol)FDA LinkGeneric
01/2016 - 08/2011
3Intrinsically Disordered ProteinsIBA
01/2013 - 04/2011
3EnzymesIBA
04/2011 - 04/2007
3AntibodiesIBA
05/2008 - 04/2002
3SteroidsIBA
10/2004 - 02/2003
3Vitamin DFDA LinkGeneric
09/2004 - 02/2002
2Estrogens (Estrogen)FDA Link
12/2020 - 02/2015
23- fluoro- N- (4- fluorophenyl)- 4- hydroxy- N- (4- hydroxyphenyl)benzamideIBA
12/2020 - 02/2015
2Estrogen Receptor alphaIBA
12/2020 - 02/2015
2Growth Differentiation Factor 15IBA
03/2014 - 06/2004
2Small Interfering RNA (siRNA)IBA
07/2013 - 04/2011
2RNA-Binding Proteins (RNA-Binding Protein)IBA
07/2013 - 05/2009
2CytokinesIBA
01/2013 - 04/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2012 - 06/2004
2CollagenIBA
01/2012 - 04/2006
2Messenger RNA (mRNA)IBA
04/2011 - 07/2008
2EpitopesIBA
08/2009 - 04/2007
2Carrier Proteins (Binding Protein)IBA
06/2009 - 07/2008
2ElementsIBA
06/2009 - 07/2008
2purineIBA
06/2009 - 07/2008
2SurvivinIBA
11/2005 - 10/2005
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2004 - 09/2004
2Calcitriol Receptors (Calcitriol Receptor)IBA
10/2004 - 09/2004
2RetinoidsIBA
10/2004 - 09/2004
21,25-dihydroxyvitamin DIBA
02/2003 - 06/2002
2Calcitriol (Calcijex)FDA LinkGeneric
02/2003 - 06/2002
2GelsIBA
10/2002 - 04/2002
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1sabizabulinIBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2020
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2020
1enzalutamideIBA
11/2019
1LigandsIBA
11/2019
1Fluconazole (Zonal)FDA LinkGeneric
10/2016
1Keratin-18 (Keratin 18)IBA
01/2016
1Phosphotransferases (Kinase)IBA
07/2015
1Formaldehyde (Formol)FDA Link
03/2015
1ParaffinIBA
03/2015
1Sex Hormone-Binding GlobulinIBA
02/2015
1vinyltriethoxysilane (VTES)IBA
02/2015
1Insulin-Like PeptidesIBA
02/2015
1Insulin-Like Growth Factor I (IGF-1)IBA
02/2015
1Leuprolide (Lupron)FDA LinkGeneric
02/2015
1Cell Surface ReceptorsIBA
10/2014
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2014
1mutacin GS-5 (GS 5)IBA
09/2014
1Transforming Growth Factor beta (TGF-beta)IBA
03/2014
1Cyclin D1IBA
07/2013
1AgarIBA
07/2013
1Epithelial Cell Adhesion MoleculeIBA
01/2013
1Inosine Diphosphate (IDP)IBA
01/2013
1VimentinIBA
01/2013
1DAPIIBA
01/2013
1Keratin-8 (Keratin 8)IBA
01/2013
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
06/2012
1Extracellular Matrix ProteinsIBA
05/2012
1Cysteine (L-Cysteine)FDA Link
05/2012
1IsoflavonesIBA
04/2012

Therapy/Procedure

18Therapeutics
12/2020 - 06/2002
4Castration
01/2022 - 01/2016
4Prostatectomy (Retropubic Prostatectomy)
03/2015 - 11/2005
2Drug Therapy (Chemotherapy)
05/2009 - 04/2008
2Radiotherapy
05/2009 - 02/2002
1Precision Medicine
07/2014
1Traction
06/2013
1Immunotherapy
06/2012